Browse by People

Ferner, R.E., Thomas, M., Mercer, G., Williams, V., Leschziner, G.D., Afridi, S.K. and Golding, J.F. (2017) Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire. Health and Quality of Life Outcomes, 15. p. 34. ISSN 1477-7525

Morris, K.A., Golding, J.F., Blesing, C., Evans, D.G., Ferner, R.E., Foweraker, K., Halliday, D., Jena, R., McBain, C., McCabe, M.G., Swampillai, A., Warner, N., Wilson, S., Parry, A. and Afridi, S. (2016) Toxicity profile of bevacizumab in the UK Neurofibromatosis Type 2 cohort. Journal of Neuro-oncology, 131. pp. 117-124. ISSN 0167-594X

Morris, K.A., Golding, J.F., Afridi, S., Blesing, C., Ferner, R.E., Halliday, D., Jena, R., Pretorius, P.M., Parry, A., Axon, P.R., Evans, D.G. and McCabe, M.G. (2016) Bevacizumab in NF2-related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation. Neuro-Oncology Practice, 3 (4). pp. 281-289. ISSN 2054-2577

Ferner, R.E., Shaw, A., Evans, D.G., McAleer, D., Halliday, D., Parry, A., Raymond F, L., Durie-Gair, J., Hanemann C, O., Hornigold, R., Axon, P.R. and Golding, J.F. (2014) Longitudinal evaluation of quality of life in 288 patients with Neurofibromatosis 2. Journal of Neurology, 26 (5). pp. 936-969. ISSN 0340-5354

Ferner, R.E., Golding, John F., Smith, M., Calonje, E., Jan, W., Sanjayanathan, V. and O'Doherty, M. (2008) [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Annals of Oncology, 19 (2). pp. 390-394. ISSN 0923-7534